These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

935 related items for PubMed ID: 20135343

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer: a meta-analysis.
    Dong X, Wu J, Liang P, Li J, Yuan L, Liu X.
    Arch Med Res; 2010 Feb; 41(2):125-33. PubMed ID: 20470942
    [Abstract] [Full Text] [Related]

  • 5. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan.
    Chou YC, Wu MH, Yu JC, Lee MS, Yang T, Shih HL, Wu TY, Sun CA.
    Carcinogenesis; 2006 Nov; 27(11):2295-300. PubMed ID: 16777985
    [Abstract] [Full Text] [Related]

  • 6. Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer.
    Boccia S, Boffetta P, Brennan P, Ricciardi G, Gianfagna F, Matsuo K, van Duijn CM, Hung RJ.
    Cancer Lett; 2009 Jan 08; 273(1):55-61. PubMed ID: 18789576
    [Abstract] [Full Text] [Related]

  • 7. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies.
    Zintzaras E.
    Psychiatr Genet; 2006 Jun 08; 16(3):105-15. PubMed ID: 16691128
    [Abstract] [Full Text] [Related]

  • 8. Methylenetetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis.
    Ren A, Wang J.
    Fertil Steril; 2006 Dec 08; 86(6):1716-22. PubMed ID: 17074326
    [Abstract] [Full Text] [Related]

  • 9. The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis.
    Yao L, Fang F, Zhong Y, Yu L.
    Breast Cancer Res Treat; 2010 Nov 08; 124(1):223-7. PubMed ID: 20204503
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.
    Yao L, Yu X, Yu L.
    Breast Cancer Res Treat; 2010 Jul 08; 122(2):503-7. PubMed ID: 20052535
    [Abstract] [Full Text] [Related]

  • 12. Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review.
    Boccia S, Hung R, Ricciardi G, Gianfagna F, Ebert MP, Fang JY, Gao CM, Götze T, Graziano F, Lacasaña-Navarro M, Lin D, López-Carrillo L, Qiao YL, Shen H, Stolzenberg-Solomon R, Takezaki T, Weng YR, Zhang FF, van Duijn CM, Boffetta P, Taioli E.
    Am J Epidemiol; 2008 Mar 01; 167(5):505-16. PubMed ID: 18162478
    [Abstract] [Full Text] [Related]

  • 13. Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.
    Qiu LX, Yao L, Mao C, Yu KD, Zhan P, Chen B, Yuan H, Zhang J, Xue K, Hu XC.
    Breast Cancer Res Treat; 2010 Jul 01; 122(2):521-5. PubMed ID: 20054636
    [Abstract] [Full Text] [Related]

  • 14. Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk.
    Lewis SJ, Harbord RM, Harris R, Smith GD.
    J Natl Cancer Inst; 2006 Nov 15; 98(22):1607-22. PubMed ID: 17105984
    [Abstract] [Full Text] [Related]

  • 15. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
    Macis D, Maisonneuve P, Johansson H, Bonanni B, Botteri E, Iodice S, Santillo B, Penco S, Gucciardo G, D'Aiuto G, Rosselli Del Turco M, Amadori M, Costa A, Decensi A.
    Breast Cancer Res Treat; 2007 Dec 15; 106(2):263-71. PubMed ID: 17260091
    [Abstract] [Full Text] [Related]

  • 16. Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects.
    Qiu LX, Yao L, Mao C, Chen B, Zhan P, Yuan H, Xue K, Zhang J, Hu XC.
    Breast Cancer Res Treat; 2010 Sep 15; 123(2):543-7. PubMed ID: 20143154
    [Abstract] [Full Text] [Related]

  • 17. 5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis.
    Pereira TV, Rudnicki M, Pereira AC, Pombo-de-Oliveira MS, Franco RF.
    Cancer Epidemiol Biomarkers Prev; 2006 Oct 15; 15(10):1956-63. PubMed ID: 17035405
    [Abstract] [Full Text] [Related]

  • 18. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer.
    Hekim N, Ergen A, Yaylim I, Yilmaz H, Zeybek U, Oztürk O, Isbir T.
    Cell Biochem Funct; 2007 Oct 15; 25(1):115-7. PubMed ID: 16134079
    [Abstract] [Full Text] [Related]

  • 19. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review.
    Gilbody S, Lewis S, Lightfoot T.
    Am J Epidemiol; 2007 Jan 01; 165(1):1-13. PubMed ID: 17074966
    [Abstract] [Full Text] [Related]

  • 20. TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47,817 subjects.
    Qiu LX, Yao L, Mao C, Chen B, Zhan P, Xue K, Zhang J, Yuan H, Hu XC.
    Breast Cancer Res Treat; 2010 Sep 01; 123(2):563-7. PubMed ID: 20143152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.